Michael Blatzer
Impact in
- Infectious Diseases top 5%
- Antifungal resistance and susceptibility
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Biological Psychiatry top 10%
Papers in
-
- Antifungal resistance and susceptibility 12
- COVID-19 Clinical Research Studies 2
- SARS-CoV-2 and COVID-19 Research 2
-
- Microbial Natural Products and Biosynthesis 4
- Co-authors
- Hubertus Haas (14 shared papers)Markus Schrettl (8 shared papers)Cornelia Lass‐Flörl (11 shared papers)Clemens Decristoforo (6 shared papers)Miloš Petřík (4 shared papers)Ulrike Binder (7 shared papers)Wilfried Posch (9 shared papers)Doris Wilflingseder (8 shared papers)
In The Last Decade
Michael Blatzer
38 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 95
- Infectious Diseases 678
- Biological Psychiatry 32
- Pharmacology 276
- Molecular Biology 630
- Radiology, Nuclear Medicine and Imaging 215
Countries citing papers authored by Michael Blatzer
This map shows the geographic impact of Michael Blatzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Blatzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Blatzer more than expected).
Fields of papers citing papers by Michael Blatzer
This network shows the impact of papers produced by Michael Blatzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Blatzer. The network helps show where Michael Blatzer may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Blatzer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 247 | |
| 2 | 2011 | 151 | |
| 3 | 2010 | 119 | |
| 4 | 2011 | 113 | |
| 5 | 2009 | 107 | |
| 6 | 2020 | 87 | |
| 7 | 2013 | 86 | |
| 8 | 2011 | 83 | |
| 9 | 2019 | 79 | |
| 10 | 2011 | 73 | |
| 11 | 2018 | 68 | |
| 12 | 2017 | 61 | |
| 13 | 2020 | 60 | |
| 14 | 2011 | 57 | |
| 15 | 2014 | 52 | |
| 16 | 2018 | 52 | |
| 17 | 2015 | 41 | |
| 18 | 2020 | 41 | |
| 19 | 2015 | 35 | |
| 20 | 2017 | 35 |
About Michael Blatzer
Michael Blatzer is a scholar working on Infectious Diseases, Pharmacology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Virology, having authored 39 papers that have together received 1.9k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (12 papers), Fungal and yeast genetics research (11 papers), Radiopharmaceutical Chemistry and Applications (6 papers), Microbial Natural Products and Biosynthesis (4 papers), COVID-19 Clinical Research Studies (2 papers), HIV Research and Treatment (2 papers), Environmental Toxicology and Ecotoxicology (2 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). The work is most often cited by research in Infectious Diseases (678 citations), Biological Psychiatry (32 citations), Pharmacology (276 citations), Molecular Biology (630 citations) and Radiology, Nuclear Medicine and Imaging (215 citations). Michael Blatzer has collaborated with scholars based in Austria, France and Germany. Frequent co-authors include Hubertus Haas, Markus Schrettl, Cornelia Lass‐Flörl, Clemens Decristoforo, Miloš Petřík, Ulrike Binder, Wilfried Posch, Doris Wilflingseder, Herbert H. Lindner and Bettina Sarg. Their work appears in journals such as Nuclear Medicine and Biology, Scientific Reports, Antimicrobial Agents and Chemotherapy, Applied and Environmental Microbiology and L Encéphale.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.